A galantamine–curcumin hybrid lacks the depressant side effect of acetylcholinesterase inhibitors
AbstractAcetylcholinesterase inhibitors (AChEIs) are drugs that enhance cholinergic neuro-transmission and are used for the treatment of Alzheimer’s disease and myasthenia gravis. Common AChEIs include rivastigmine, donepezil and galantamine (GAL), but they can cause side effects like nausea, vomiti...
Main Authors: | Ivanka Kostadinova, Mariyana Atanasova, Georgi Stavrakov, Irena Philipova, Irini Doytchinova |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-01-01
|
Series: | Biotechnology & Biotechnological Equipment |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/13102818.2024.2305903 |
Similar Items
-
Ex Vivo Antioxidant and Cholinesterase Inhibiting Effects of a Novel Galantamine–Curcumin Hybrid on Scopolamine-Induced Neurotoxicity in Mice
by: Rumyana Simeonova, et al.
Published: (2022-11-01) -
A Galantamine–Curcumin Hybrid Decreases the Cytotoxicity of Amyloid-Beta Peptide on SH-SY5Y Cells
by: Kirilka Mladenova, et al.
Published: (2021-07-01) -
A Novel Galantamine-Curcumin Hybrid as a Potential Multi-Target Agent against Neurodegenerative Disorders
by: Rumyana Simeonova, et al.
Published: (2021-03-01) -
Discovery of a Novel Acetylcholinesterase Inhibitor by Fragment-Based Design and Virtual Screening
by: Georgi Stavrakov, et al.
Published: (2021-04-01) -
Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors
by: Georgi Stavrakov, et al.
Published: (2020-07-01)